Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products
We do not prescribe Ozempic for weight loss
Exp: 04/26 Original price was: 4,980.Current price is: 2,980
2.4.4.1 Serotonin In rats, serotonin stimulates GH secretion, whereas in humans, stimulation or inhibition or even no effect has been described [53]
Herzenberg, Ph.D., Thomas W
Any pen that has been frozen must be discarded immediately, even if it appears normal, as freezing causes irreversible changes that cannot be detected by visual inspection